Exploring how genetics can improve drug therapy and development
Pharmaceutical Sciences and Pharmacogenomics
This study at UCSF is all about helping doctors create better, personalized medications by using genetic information, and it's designed for Ph.D. students who want to learn how to make these advancements in drug therapy.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10837729 on NIH RePORTER |
What this research studies
This research program at the University of California, San Francisco focuses on the intersection of pharmaceutical sciences and pharmacogenomics, aiming to enhance drug development and precision medicine. It trains Ph.D. students to design and conduct innovative research that applies genetic insights to optimize drug therapies for individual patients. The program encompasses a wide range of topics, including drug delivery, gene therapy, and the pharmacokinetics of medications, ensuring a comprehensive understanding of how to tailor treatments based on genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in how their genetic makeup can influence their response to medications.
Not a fit: Patients who do not have access to genetic testing or those with conditions not addressed by current pharmacogenomic approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized drug therapies for patients, improving treatment outcomes.
How similar studies have performed: Previous research in pharmacogenomics has shown promising results in personalizing drug therapies, indicating a strong potential for success in this area.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Guo, Su — University of California, San Francisco
- Study coordinator: Guo, Su
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.